Inotiv Gross Profit Over Time
NOTV Stock | USD 3.75 0.16 4.46% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Inotiv Performance and Inotiv Correlation. Inotiv |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inotiv. If investors know Inotiv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inotiv listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.84) | Revenue Per Share 19.444 | Quarterly Revenue Growth (0.33) | Return On Assets (0.03) | Return On Equity (0.43) |
The market value of Inotiv Inc is measured differently than its book value, which is the value of Inotiv that is recorded on the company's balance sheet. Investors also form their own opinion of Inotiv's value that differs from its market value or its book value, called intrinsic value, which is Inotiv's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inotiv's market value can be influenced by many factors that don't directly affect Inotiv's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inotiv's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inotiv is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inotiv's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Gross Profit Analysis
Compare Inotiv Inc and related stocks such as Fonar, Burning Rock Biotech, and Sera Prognostics Gross Profit Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FONR | 1.1 M | 18.2 M | 23 M | 31.3 M | 30.6 M | 34.5 M | 40 M | 39.6 M | 43.2 M | 42.4 M | 43.5 M | 47 M | 45.7 M | 45.1 M | 23 M |
BNR | 71.7 M | 71.7 M | 71.7 M | 71.7 M | 71.7 M | 71.7 M | 71.7 M | 71.7 M | 135.1 M | 273.3 M | 313.9 M | 364.1 M | 380 M | 363.2 M | 298.8 M |
SERA | 18 K | 18 K | 18 K | 18 K | 18 K | 18 K | 18 K | 18 K | 18 K | 18 K | 14 K | 45 K | 75 K | 96 K | 54.6 K |
XGN | (1 M) | (1 M) | (1 M) | 225 K | 4.8 M | 8.4 M | 12.7 M | 12.7 M | 17.1 M | 21.6 M | 25.4 M | 27.7 M | 21.3 M | 29.5 M | 16.8 M |
SHC | 357.3 M | 357.3 M | 357.3 M | 357.3 M | 357.3 M | 357.3 M | 357.3 M | 357.3 M | 357.3 M | 395.4 M | 443.6 M | 518.7 M | 557 M | 577.2 M | 522.3 M |
DRIO | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (2.2 M) | (855 K) | (561 K) | 1.3 M | 1.8 M | 2.6 M | 2.5 M | 4 M | 9.7 M | 6 M | 6.3 M |
STIM | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 30.8 M | 40.3 M | 47.3 M | 37.7 M | 43.7 M | 49.7 M | 51.7 M | 45.2 M |
MDXH | 513.8 K | 3.1 M | 3.7 M | 1.8 M | 5 M | 10.6 M | 19.8 M | 30.3 M | 16.7 M | (144 K) | 7.8 M | 10.4 M | 19.2 M | 43.9 M | 46.1 M |
Inotiv Inc and related stocks such as Fonar, Burning Rock Biotech, and Sera Prognostics Gross Profit description
Gross profit is a required income statement account that reflects total revenue of Inotiv Inc minus its cost of goods sold. It is profit before Inotiv operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.My Equities
My Current Equities and Potential Positions
Inotiv Inc | NOTV |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Indiana; U.S.A |
Exchange | NASDAQ Exchange |
USD 3.75
Additional Tools for Inotiv Stock Analysis
When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.